Intrinsiqs

Is Progyny, Inc. overvalued?

Progyny, Inc. (PGNY) looks undervalued — trading about 142% below its fair value.

Undervalued
Current price $25.48 Fair value $61.65
Price
$25.48
Fair value
$61.65
Current P/E
18.6
Normal P/E
45.0
Market cap
$2.00B
Dividend yield
0.0%
Return on equity
16.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PGNY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated